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Development of PDIA3 Knockout Human Osteosarcoma SaOs-2 
Cells Using CRISPR-Cas9
Pyburn J, Razskazovskiy V, Hagg T, Keasey M.P.
Introduction:
Vitamin D signaling is involved in physiological calcification as well as in 
pathological conditions such as Fahr’s disease (Keasey et al, 2016). The 
discovery of Vitamin D’s in vitro role in calcification of human osteosarcoma 
SaOs-2 cells has led to further exploration of Vitamin D related signalling. The 
active metabolite of Vitamin D, calcitriol, exerts its intracellular  effects 
through its interaction with protein disulfide isomerase A3 (PDIA3) at the 
plasma membrane. Using CRISPR-Cas9, the PDIA3 gene can be mutated in 
cells to knock out protein expression.This allows for in vitro cell culture 
manipulations to elucidate the role of calcitriol-PDIA3 signaling in calcification. 
To better understand the role of PDIA3 mediated vitamin D signaling in 
calcification, we chose to develop a cell line deficient in PDIA3 by CRISPR-
Cas9. Using CHOP-CHOP, a gRNA selecting software which chooses 
sequences with low predicted non-specific binding probabilities, we selected 
gRNAs targeting exon 1 of PDIA3. The most specific gRNA was directionally 
cloned into a Cas9 plasmid, which along with a puromycin resistance gene 
plasmid, were transfected into SaOs cells. Subsequently, cells were  treated 
with puromycin to eliminate non-transfected cells. Next, we isolated multiple 
homogenous populations of cells, each derived from a single transfected cell, 
and the expression of PDIA3 mRNA and protein was quantified for each 
colony. With successful confirmation of total PDIA3 knockout, further research 
can now begin into how calcitriol-PDIA3 signaling relates to calcification in 
vitro.
Methods:
Cloning: A gRNA targeting  exon 1 of PDIA3 was created with the following 
primers: forward 5‘GTGGCGCTGCTTCTTGCCG’3 and reverse 
complementary 5‘CGGCAAGAAGCAGCGCCACA’3. For cloning of the gRNA 
into the CRISPR-Cas9 plasmid, a “GATCG” overhang  was appended to the 
5’ end and “G” was appended to the 3’ end of the forward strand. For the 
reverse strand “AAAC” was appended on the 5’ end and “C” was appended to 
the 3’ end. Restriction enzymes BamH1 and BsmB1 were used to digest the 
plasmid producing overhangs compatible with the annealed gRNA 
oligonucleotide. Ligation was carried out using standard protocol and the 
plasmid was amplified in DH5 E. Coli with ampicillin selection. Identity of the 
plasmid was confirmed by agarose gel electrophoresis.
Cell culture: SaOs cells were maintained in DMEM supplemented with 10% 
FBS and 2mM L-glutamine.  The cells were housed in a T75 flask and were 
passaged once reaching 90% confluency or every 3-4 days. After passaging, 
2.0E6 cells were placed back in each flask, kept at 5% CO2 at 37°C.
qPCR:RNA was isolated using the OmegaBiotek RNEasy kit according to the 
manufacturer’s protocol. qPCR was carried out as previously described 
(Keasey et al, 2013) and analyzed using the ΔΔCT method.
Western blotting: Proteins were isolated in RIPA buffer supplemented with 
PMSF and Western blotting was carried out as previously described (Keasey 
et al, 2013). Primary and secondary antibody incubation was completed in 
0.5% milk in TBST. Primary antibody dilutions were: ERp57-1:1000 and 
GAPDH - 1:3000.  The secondary antibody dilution was 1:5000.
Conclusion:
● PDIA3 protein was completely knocked out for use in further analysis and experimentation on the signaling of and the 
role of Vitamin D in calcification processes in vitro. 
● After multiple passages, morphological differences have been observed between the SaOs-2 WT and SaOs-2 PDIA3 
KO cells. 
● Future steps will include comparison of the ability of WT SaOs cells to undergo calcification relative to PDIA3 KO cells 
as well as investigation into PDIA3’s role in regulating expression of mineral transporters involved in calcification.
● Though it has been reported that whole organism knock out of PDIA3 is lethal at E13.5 in mice (Coe et al, 2009), our 
PDIA3 KO SaOs cells successfully grow in culture.  
● Apoptosis and cellular growth rates remain to be characterized.
Figure 1: gRNA Selection Using CHOPCHOP Software
Figure 2: (A) Transfection of Cells with Cas9-gRNA 
plasmid and subsequent puromycin selection. (B) 
Single cell colonies were picked for analysis of 
PDIA3 mRNA expression. Here, it is seen that 
colonies 2 and 10 display completely knocked out 
PDIA3 mRNA expression. Colony 2 (red arrow) was 
selected for further characterization and confirmation 
of PDIA3 knockout. 
Figure 4: Colony 2 was selected for further investigation. RT-qPCR (A) and 
western blotting (B) confirm 100% knock out of PDIA3 in SaOs-2 cells 
(p<0.001**, Student’s t-test, n=3). Brightfield images (C) demonstrate 
morphology of wild type (WT) and PDIA3 KO cells. 
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Figure 3: Ligation of guideRNA oligonucleotides into 
pCas-Guide plasmid. (A) Restriction digest with BamHi 
and BsmB I was followed by sticky end (red font) ligation 
of gRNA oligonucleotides into pCas-Guide vectors .  
Diagram B depicts the mapping of the genes for the 
Cas9-gRNA expression plasmid.
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